Merck & Co Inc BDR (MRCK34)


Symbol		Exchange		Currency
MRCK34	·	B3	·	BRL	Delayed
MRK	·	NYSE	·	USD	Real-time
0QAH	·	London	·	USD	Real-time
MRK	·	Mexico	·	MXN	Delayed
1MRKX	·	Milan	·	EUR	Real-time
MRK	·	Xetra	·	EUR	Delayed
MRK	·	Frankfurt	·	EUR	Delayed
MRK	·	TradeGate	·	EUR	Delayed
MRKm	·	Buenos Aires	·	ARS	Delayed
MRK	·	Vienna	·	EUR	Real-time
MRK	·	Ukraine	·	UAH	Delayed
MRK	·	Lima	·	USD	Delayed

Currency in BRL

54.29

-0.08(-0.15%)

Delayed Data·14:32:29

Fair Value

Unlock Value

Day's Range

53.57

54.45

52 wk Range

51.60

93.08

MRCK34 Income Statement

Explore the detailed Merck Co Inc BDR income statement, offering a comprehensive view of the company’s financial performance. Review essential metrics such as revenue, gross profit, operating income, and net income over selected periods. This page provides a clear breakdown of profitability and operational efficiency, helping you evaluate Merck Co Inc BDR's growth trends and overall financial health.

Advanced Income Statement

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Total Revenues

aa.aa

41,518

48,704

59,283

60,115

64,168

Total Revenues Growth

aa.aa

+6.13%

+17.31%

+21.72%

+1.4%

+6.74%

Cost Of Revenues

aa.aa

11,990

13,466

17,206

15,915

14,698

Gross Profit

aa.aa

29,528

35,238

42,077

44,200

49,470

Gross Profit Growth

aa.aa

+5.23%

+19.34%

+19.41%

+5.05%

+11.92%

Gross Profit Margin %

aa.aa

71.12%

72.35%

70.98%

73.53%

77.09%

Other Operating Expenses, Total

aa.aa

19,133

21,345

21,587

28,226

24,581

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+9.81%	+11.56%	+1.13%	+30.75%	-12.91%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	10,564	11,942	11,918	18,342	14,481
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	8,569	9,403	9,669	9,884	10,100
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

10,395

13,893

20,490

15,974

24,889

Operating Income Growth

aa.aa

-2.28%

+33.65%

+47.48%

-22.04%

+55.81%

EBIT Margin %

aa.aa

25.04%

28.53%

34.56%

26.57%

38.79%

Net Interest Expenses

aa.aa

-713

-770

-805

-781

-856

Net Interest Expenses Growth

aa.aa

-15.19%

-7.99%

-4.55%

+2.98%

-9.6%

Interest Expense, Total

aa.aa

-831

-806

-962

-1,146

-1,271

Interest And Investment Income

aa.aa

118

157

365

415

Other Non Operating Expenses, Total

aa.aa

-74

-41

444

49.5

EBT, Excl. Unusual Items

aa.aa

9,608

13,082

20,129

15,242.5

24,096

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

-90

-275

-1,600

-1,351.5

170

EBT, Incl. Unusual Items

aa.aa

5,863

13,879

16,444

1,889

19,936

EBT, Incl. Unusual Items Growth

aa.aa

-18.24%

+136.72%

+18.48%

-88.51%

+955.37%

EBT, Incl. Unusual Items Margin

aa.aa

14.12%

28.5%

27.74%

3.14%

31.07%

Income Tax Expense

aa.aa

1,340

1,521

1,918

1,512

2,803

Net Income to Company

aa.aa

7,071

13,062

14,526

377

17,133

Minority Interest

aa.aa

-4

-13

-7

-12

-16

Net Income

aa.aa

7,067

13,049

14,519

365

17,117

Net Income Growth

aa.aa

-28.2%

+84.65%

+11.27%

-97.49%

+4,589.59%

Net Income Margin %

aa.aa

17.02%

26.79%

24.49%

0.61%

26.68%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

4,519

12,345

14,519

365

17,117

Basic EPS - Continuing Operations

aa.aa

1.79

4.88

5.73

0.14

6.76

Basic EPS - Continuing Operations Growth

aa.aa

-19.48%

+173.18%

+17.52%

-97.49%

+4,598.87%

Diluted EPS - Continuing Operations

aa.aa

1.78

4.86

5.71

0.14

6.74

Diluted EPS - Continuing Operations Growth

aa.aa

-19.46%

+173.03%

+17.49%

-97.55%

+4,714.29%

Basic Weighted Average Shares Outstanding

aa.aa

2,530

2,532

2,537

2,532

Diluted Weighted Average Shares Outstanding

aa.aa

2,541

2,538

2,542

2,547

2,541

Dividend Per Share

aa.aa

2.44

2.6

2.76

2.92

3.08

Dividend Per Share Growth

aa.aa

+10.91%

+6.56%

+6.15%

+5.8%

+5.48%

EBITDA

aa.aa

13,613

17,016

24,279

19,706

29,134

EBITDA Growth

aa.aa

-0.74%

+25%

+42.68%

-18.84%

+47.84%

EBITDA Margin %

aa.aa

32.79%

34.94%

40.95%

32.78%

45.4%

EBIT

aa.aa

10,395

13,893

20,490

15,974

24,889

* In Millions of USD (except for per share items)

US 30

42,729.90

+75.2

+0.18%

US 500

5,952.80

-5.6

-0.09%

Dow Jones

42,731.72

+76.98

+0.18%

S&P 500

5,952.43

-5.95

-0.10%

Nasdaq

19,167.94

-43.17

-0.23%

S&P 500 VIX

18.00

+0.76

+4.41%

Dollar Index

100.307

-0.639

-0.63%

Market Movers

Name	Last	Chg. %	Vol.
NVDA	135.10	-0.23%	151.95M
TSLA	340.24	-2.78%	71.22M
PLTR	126.20	-2.56%	59.58M
UNH	311.85	+6.83%	51.44M
AAPL	208.32	-1.39%	30.69M
AMZN	206.08	+0.24%	21.97M
MSFT	458.31	+0.89%	12.57M

Trending Stocks

Name	Last	Chg. %	Vol.
NVDA	135.10	-0.23%	151.95M
TSLA	340.24	-2.78%	71.22M
UNH	311.94	+6.86%	51.52M
PLTR	126.20	-2.57%	59.65M
SMCI	45.25	-1.95%	37.72M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aa Aaaaa Aaaaa	35.32	+40.58%	49.65
Aaaaaaaaa	321.32	+38.51%	445.06
Aaaaaaaaaaaaa Aa	76.03	+36.11%	103.48
Aaa Aa A Aaaaaaaa	106.22	+28.46%	136.45
Aaaaaa A	90.09	+27.39%	114.77
Aaaaaaaa Aaaa A	138.00	+26.25%	174.22
Aaaaaaaa Aaaaaaa Aa	27.80	+22.04%	33.93

Name	Last	Upside	Fair Value
Aa Aaaaa Aaaaa	35.32	+40.58%	49.65
Aaaaaaaaa	321.32	+38.51%	445.06
Aaaaaaaaaaaaa Aa	76.03	+36.11%	103.48
Aaa Aa A Aaaaaaaa	106.22	+28.46%	136.45
Aaaaaa A	90.09	+27.39%	114.77
Aaaaaaaa Aaaa A	138.00	+26.25%	174.22
Aaaaaaaa Aaaaaaa Aa	27.80	+22.04%	33.93

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Name	Last	Chg. %	Vol.
UNH	311.94	+6.86%	51.52M
MRNA	26.42	+6.28%	12.61M
DG	97.85	+4.60%	3.04M
GEV	444.87	+3.93%	2.29M
HUM	246.19	+3.46%	1.38M
TTWO	233.84	+3.13%	1.30M
GILD	105.32	+2.75%	4.41M

Name	Last	Chg. %	Vol.
FSLR	160.95	-9.81%	7.99M
ENPH	48.15	-4.46%	3.31M
AES	11.68	-4.38%	13.48M
CZR	29.44	-4.12%	1.90M
BBY	71.23	-3.48%	1.74M
ARM	130.92	-3.71%	3.04M
CE	51.99	-2.87%	694.15K

Popular Searches

Please try another search

Merck & Co Inc BDR (MRCK34)

MRCK34 Income Statement

Trending Stocks